[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338787-105":59,"doc-detail-338787-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","histone-acetylation-a-key-determinant-of-acquired-cisplatin-resistance-in-cancer","Histone acetylation: a key determinant of acquired cisplatin resistance in cancer","","Cisplatin is an alkylating chemotherapy used for cancer treatment, but long-term use often fails due to acquired drug resistance, leading to tumor recurrence. This study develops in vitro cisplatin-resistant cancer cell line models and analyzes parental versus resistant cells. Gene ontology and GSEA indicate changes in PI3K-AKT signaling, central carbon metabolism, and epigenetic-associated phenomena. Increased glucose transport, altered histone-modifying enzyme activity, and elevated acetyl-CoA align with higher global histone acetylation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/histone-acetylation-a-key-determinant-of-acquired-cisplatin-resistance-in-cancer/338787/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/histone-acetylation-a-key-determinant-of-acquired-cisplatin-resistance-in-cancer/338787.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is understanding acquired cisplatin resistance important?","Question",{"text":112,"@type":113},"Cisplatin treatment often fails in the long term, and drug resistance drives tumor recurrence. Understanding how chemoresistance is acquired supports development of new combination therapeutic strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were cisplatin-resistant cancer cells modeled in the study?",{"text":117,"@type":113},"In vitro cisplatin-resistant cancer cell line models were developed to compare parental and resistant cell states and measure molecular differences.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does histone acetylation play in cisplatin resistance?",{"text":121,"@type":113},"Resistant cells show increased global histone acetylation, linked to higher glucose transport, altered histone-modifying enzyme activity, and increased acetyl-CoA. Enrichment of histone acetylation on PI3K-AKT and glycolysis effectors supports epigenetic regulation of resistance-relevant molecules.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338787,1790197178,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Natu et al. Clinical Epigenetics (2024) 16:8 [https://doi.org/10.1186/s13148-023-01615-5](https://doi.org/10.1186/s13148-023-01615-5)  \nClinical Epigenetics  \n RESEARCH Open Access  \nHistone acetylation: a key determinant of acquired cisplatin resistance in cancer  \nAbhiram Natu 1,2, Tripti Verma1,2, Bharat Khade1, Rahul Thorat3, Poonam Gera4, Sangita Dhara2,5 and Sanjay Gupta1,2*  \nAbstract  \nCisplatin is an alkylating class of chemotherapeutic drugs used to treat cancer patients. However, cisplatin fails in longterm treatment, and drug resistance is the primary reason for tumor recurrence. Hence, understanding the mechanism of acquirement of chemoresistance is essential for developing novel combination therapeutic approaches. In this study, in vitro cisplatin-resistant cancer cell line models were developed. Gene ontology and GSEA of differentially expressed genes between parental and resistant cells suggest that PI3K-AKT signaling, central carbon metabolism, and epigenetic-associated phenomenon alter in cisplatin-resistant cells. Further, the data showed that increased glucose transport, alteration in the activity of histone-modifying enzymes, and acetyl-CoA levels in resistant cells paralleled an increase in global histone acetylation. Enrichment of histone acetylation on effectors of PI3K-AKT and glycolysis pathway provides evidence of epigenetic regulation of the key molecules in drug resistance. Moreover, cisplatin treatment to resistant cells showed no significant changes in histone acetylation marks since drug treatment alters cell epigenome. In continuation, targeting PI3K-AKT signaling and glycolysis leads to alteration in histone acetylation levels and re-sensitization of resistant cells to chemo-drug. The data provide evidence of histone acetylation’s importance in regulating pathways and cisplatin-resistant cells’ cell survival. Our study paves the way for new approaches for developing personalized therapies in affecting metabolic pathways and epigenetic changes to achieve better outcomes for targeting drug-resistant cells.  \nKeywords Cisplatin, Resistance, Hyperacetylation, PI3K, 2DG  \n*Correspondence: Sanjay Gupta[sgupta@actrec.gov.in](sgupta@actrec.gov.in)  \n1 Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, MH 410210, India  \n2 Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, MH 400094, India  \n3 Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India  \n4 Biorepository, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai 410210, India  \n5 Fuel Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India  \nIntroduction  \nCisplatin, a first-generation platinum drug, is used as a first-line therapy in clinical practice for treating various solid tumors, including ovarian, cervical, lung, stomach, head and neck, liver, and breast cancers [1]. Its efficacy has been demonstrated in previous studies, attributed to its ability to produce a variety of DNA-platinum adducts, resulting in double-stranded DNA damage and triggering mitochondrial apoptosis [2]. Despite being effective against a variety of cancer types, cisplatin treatment frequently encounters resistance, which results in treatment failure.  \nThe mechanism of cisplatin resistance involves altered signal regulation networks in tumor cells, a strong ability to prevent apoptosis, decreased drug  \n© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons lic","cbCaipByRkbKPObN","https://ap.wps.com/l/cbCaipByRkbKPObN","pdf",2669334,15,"English","# Abstract\n# Introduction","[{\"question\":\"Why is understanding acquired cisplatin resistance important?\",\"answer\":\"Cisplatin treatment often fails in the long term, and drug resistance drives tumor recurrence. Understanding how chemoresistance is acquired supports development of new combination therapeutic strategies.\"},{\"question\":\"How were cisplatin-resistant cancer cells modeled in the study?\",\"answer\":\"In vitro cisplatin-resistant cancer cell line models were developed to compare parental and resistant cell states and measure molecular differences.\"},{\"question\":\"What role does histone acetylation play in cisplatin resistance?\",\"answer\":\"Resistant cells show increased global histone acetylation, linked to higher glucose transport, altered histone-modifying enzyme activity, and increased acetyl-CoA. Enrichment of histone acetylation on PI3K-AKT and glycolysis effectors supports epigenetic regulation of resistance-relevant molecules.\"}]","Histone acetylation: a key determinant of acquired cisplatin resistance in cancer | PDF",1790025647,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2cf924180e6a08ebac39b22f76b8768.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/823cf6e1a5f3860ce418afda17a8c450.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/970a629dbd3c04054335b0a37e40f36c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a3c4bc326888bba5358cc2c94814a76.webp",980,1301]